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Case presentation  
A 17-year old boy was referred from the general practitioner to the local psychosis early detection 
clinic due to a drop in functioning and social withdrawal over the previous six months. Concerned 
about his increasing social isolation, his mother encouraged him to seek help. He began college six 
months prior but had found the workload difficult, failing his exams. During this period, he reported 
that he could not relate to people at college or to friends. He had no family history of mental 
disorders, denied any current or past use of drugs and reported no significant medical history. He was 
well kempt, quiet during his interview, providing short answers. He reported that he no longer 
enjoyed his former interests, but there were no clear signs of depressive disorders. No formal thought 
disorders were elicited. He believed that random people looked and talked about him when he was out 
in public. He was 80% convinced that this was occurring but was able to question it. He stated that 
these people were probably commenting on the way he looked but he did not believe these individuals 
meant him harm. He never acted on these thoughts. He also reported a vague feeling of perplexity and 
derealisation. These experiences began when he started college and continued to occur every day for 
up to an hour at a time (if he was outside), causing significant distress. At the Structured Clinical 
Interview for DSM he did not meet diagnostic criteria for any mental disorder. 
 
Prognosis 
Clinical High Risk for Psychosis (CHR-P1), Attenuated Psychotic Symptoms subgroup, determined 
using the Comprehensive Assessment of At Risk Mental States (CAARMS)2. Increased risk of 
developing psychosis: 26% at 3 years (95%CI 23% - 30%)3.  
 
What Would You Do Next? 
A Discharge to general practitioner with no clinical 
recommendations  
B Pharmacotherapy with low dose atypical 
antipsychotics 
C Clinical follow-up for at least 3 years and indicated 
primary prevention 
D Treatment with omega-3 fish oil dietary 
supplementation 
What to do next 
C. Clinical follow-up for at least 3 years and indicated primary prevention.  
Discussion  
Children, adolescents and young adults (aged 8-40) who seek help at specialised early detection 
clinics have an enhanced risk of developing mental disorders -such as psychosis- compared to the 
local age-matched general population (15%4 vs 0.43%5 at 3 years, respectively, Figure 1). Fully 
addressing their presenting problems requires forecasting their risk -i.e. probability- of developing 
future outcomes. The development of semi-structured psychometric interviews (prognostic tools) to 
assess CHR-P criteria has allowed formulating a prognosis of being at risk or not at risk for 
psychosis3. The original prognostic tool in this field (the CAARMS2) was developed on the basis of 
accumulating knowledge of the specific symptoms that may predate the onset of psychosis (defined as 
binary outcome). The CAARMS is transdiagnostic, allowing the presence of several comorbid mental 
disorders at baseline, which are frequent in these patients6. Specific training is needed to use it and its 
administration usually requires 2 hours in the context of a clinical assessment7. Extensive 
international validation has confirmed that, in people referred to psychosis early detection services, 
the CAARMS has an adequate prognostic performance, comparable to other prognostic instruments 
used in medicine3. Viceversa, it does not work well outside these samples3. Its potentials include a 
good ability to rule out a state of risk for psychosis, while its limitations include only a moderate 
ability to rule in a state of risk for psychosis (Figure 1)4. This prognostic tool has allowed one of the 
first preventive approaches to psychotic disorders to be implemented in psychiatry8. Several other 
variants of the CAARMS have been developed, with almost comparable prognostic performance3. 
The use of these prognostic tools in individuals seeking help at psychosis early detection clinics can 
impact their clinical management by: (i) informing patients about their risk of developing psychosis, 
(ii) establishing whether clinical monitoring for the outcome is required, and (iii) deciding whether to 
initiate preventive treatments or not. 
 
Our patient was meeting the CHR-P criteria and therefore was predicted to have an enhanced risk -
26% at 3 years3 (Figure 1)- of developing emerging psychotic disorders over time, compared to help-
seeking individuals not meeting CHR-P criteria (who have only 1.56% risk of developing psychosis at 
3 years3, Figure 1). First, we have shared with our patient the result of the prognostic test, in the 
context of psychoeducational support offered by psychosis early detection clinics. Informing patients 
about their risks is an essential component of preventive approaches in all branches of medicine. For 
example, CHR-P individuals accumulate several risk factors for psychosis, some of which may be 
potentially modifiable9. The second clinical impact of our prognostic assessment was to recommend 
close clinical monitoring over the ensuing 3 years, because this is the peak of risk3. Monitoring for 
adverse clinical outcomes is per se clinically helpful because we would be ready to intervene in the 
case of clinical deterioration. Finally, our patient was offered specific preventive interventions 
(termed indicated primary prevention) that were based on psychological therapies (cognitive 
behavioural therapy). These treatments aim at improving the presenting symptoms and disability10 and 
to stop the progression to psychosis. Although psychological therapies are currently recommended 
(while antipsychotics are not recommended)8, their effectiveness is not fully established and other 
experimental therapeutics have been investigated. Over the past years, omega-3 interventions have 
received high levels of interest because of their benign profile, but they were recently found not to be 
effective. The first ever pharmaceutical-funded randomised controlled trial in these patients (testing a 
phosphodiesterase-9 inhibitor) has just started and involves risk stratification, confirming that 
forecasting risk through prognosis is becoming a cornerstone of preventive psychiatry. Recent 
developments in prognostic tools might additionally allow prediction (and potential prevention) of the 
onset of mental disorders other than psychosis11. 
Figure 1. Prognostic tools for forecasting emerging mental disorders (psychosis). Individuals seeking 
help at specialised psychosis early detection clinics have a higher risk of developing psychosis (15% 
at 3 years4) than the general population (0.43% at 3 years)5. Those who will meet the Clinical High 
Risk for Psychosis (CHR-P) criteria at the prognostic interview (CAARMS) will have only a modest 
increase in their level of risk for psychosis (1.8-fold, from 15% to 26%). Those not meeting the CHR-
P criteria3 will have a substantial decrease of their risk (9-fold, from 15% to 1.56%). 
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